Question: Gujarat-based Zydus Cadila has recently sought approval from government of India for emergency uses of its Covid-19 vaccine, ZyCoV-D. This vaccine production uses which method to make the vaccine?
a) mRNA
b) Live attenuated virus
c) DNA
d) Dead Virus
Ans: c
Context
- Indian pharmaceutical company Zydus Cadila may approach drugs regulator DCGI for emergency approval of its Covid-19 vaccine Zycov-D.
Facts
- ZyCoV-D will be the first first DNA-based Covid vaccine in the world if it gets approved by the regulator.
- It is a three-dose vaccine. According to Zydus Cadila, the three doses of Zycov-D are to be administered at day 0, day 28 and day 56.
- The company is also working on a two-dose vaccine.
- If approved this will become the fourth vaccine to be administered in the country after Serum Institute’s Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V. It will also be the second indigenous vaccine after Bharat Biotech’s Covaxin.
How ZyCoV-D is different from other vaccines
- A DNA vaccine carries into the body the genetic code for that part of a virus that triggers the immune system of the body.
- The message is decoded using the host cell’s own machinery to produce that antigen and stimulate the immune system.
- When later on an actual infection occurs and the SARS-CoV2 enters the body, the immune system is already prepped to recognise it and knows what are the most effective ways to fight it.
- Other vaccines like ones made by Pfizer and Moderna also uses this method to produce vaccines what is known as “nucleic acid vaccines”. But the difference is that they use messenger RNA while ZyCoV-D uses plasmid — a DNA fragment capable of surviving outside of the nucleus of a cell.
By kameshwar Shukla